Reduction in post-operative acute kidney injury following a change in antibiotic prophylaxis policy for orthopaedic surgery: An observational study

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 9, 2016, Pages 2598-2605

  Walker, Heather ^a   Patton, Andrea ^b   Bayne, Gwen ^c   Marwick, Charis ^b   Sneddon, Jacqueline ^c   Davey, Peter ^b   Nathwani, Dilip ^c   Bell, Samira ^a  

^a NINEWELLS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c DoH Advisory Committee on Antibiotic Resistance and Healthcare Acquired Infections   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; FLUCLOXACILLIN; GENTAMICIN;

ACUTE KIDNEY INJURY; AGED; ANTIBIOTIC PROPHYLAXIS; EPIDEMIOLOGY; FEMALE; HEALTH CARE POLICY; HEALTH SERVICES RESEARCH; HUMAN; INCIDENCE; MALE; MIDDLE AGED; ORGANIZATIONAL POLICY; ORTHOPEDIC SURGERY; PROCEDURES; VERY ELDERLY;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; FEMALE; FLOXACILLIN; GENTAMICINS; HEALTH POLICY; HEALTH SERVICES RESEARCH; HUMANS; INCIDENCE; INTERRUPTED TIME SERIES ANALYSIS; MALE; MIDDLE AGED; ORGANIZATIONAL POLICY; ORTHOPEDIC PROCEDURES;

EID: 85026520729     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw166     Document Type: Article

References (45)

1. Plowman R. The socioeconomic burden of hospital acquired infection. Euro Surveill 2000; 5: 49-50.
2. Whitehouse JD, Friedman ND, Kirkland KB et al. The impact of surgicalsite infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002; 23: 183-9.
3. AlBuhairan B, Hind D, Hutchinson A. Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. J Bone Joint Surg Br 2008; 90: 915-9.
4. Scottish Intercollegiate Guidelines Network (SIGN). Antibiotic Prophylaxis in Surgery. Edinburgh: SIGN, 2014.
5. Uckay I, Hoffmeyer P, Lew D et al. Prevention of surgical site infections in orthopaedic surgery and bone trauma: state-of-the-art update. J Hosp Infect 2013; 84: 5-12.
6. Goossens H, Ferech M, Vander Stichele R et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-87.
7. Bell S, Davey P, Nathwani D et al. Risk of AKI with gentamicin as surgical prophylaxis. J Am Soc Nephrol 2014; 25: 2625-32.
8. Challagundla SR, Knox D, Hawkins A et al. Renal impairment after highdose flucloxacillin and single-dose gentamicin prophylaxis in patients undergoing elective hip and knee replacement. Nephrol Dial Transplant 2013; 28: 612-9.
9. Bailey O, Torkington MS, Anthony I et al. Antibiotic-related acute kidney injury in patients undergoing elective joint replacement. Bone Joint J 2014; 96-B: 395-8.
10. Craxford S, Bayley E, Needoff M. Antibiotic-associated complications following lower limb arthroplasty: a comparison of two prophylactic regimes. Eur J Orthop Surg Traumatol 2014; 24: 539-43.
11. Bartlett JG. Historical perspectives on studies of Clostridium difficile and C. difficile infection. Clin Infect Dis 2008; 46 Suppl 1: S4-11.
12. Carignan A, Allard C, Pepin J et al. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clin Infect Dis 2008; 46: 1838-43.
13. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996; 275: 1489-94.
14. Uchino S, Bellomo R, Goldsmith D et al. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006; 34: 1913-7.
15. Chertow GM, Levy EM, Hammermeister KE et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998; 104: 343-8.
16. Bell S, Dekker FW, Vadiveloo Tet al. Risk of postoperative AKI in patients undergoing orthopaedic surgery-development and validation of a risk score and effect of AKI on survival; an observational cohort study. BMJ 2015; 351: doi:10.1136/bmj.h5639.
17. Shusterman N, Strom BL, Murray TG et al. Risk factors and outcome of hospital-acquired acute renal failure. Clinical epidemiologic study. Am J Med 1987; 83: 65-71.
18. Kheterpal S, Tremper KK, Englesbe MJ et al. Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology 2007; 107: 892-902.
19. Chertow GM, Burdick E, Honour M et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005; 16: 3365-70.
20. Coca SG, Yusuf B, Shlipak MGet al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 53: 961-73.
21. Pepin J, Valiquette L, Alary ME et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004; 171: 466-72.
22. Health Protection Scotland. Annual Report on the Surveillance of Clostridium difficile-Associated Disease (CDAD) in Scotland, October 2007-September 2008. http://www.hps.scot.nhs.uk/haiic/sshaip/wrdetail. aspx?id=36578&wrtype=6.
23. PHE. Clostridium difficile: Guidance, Data and Analysis. https://www. gov.uk/government/collections/clostridium-difficile-guidance-data-andanalysis.
24. Hensgens MP, Goorhuis A, Dekkers OM et al. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother 2012; 67: 742-8.
25. Scottish Antimicrobial Prescribing Group. Guidance to Optimise Antimicrobial Use and Reduce Clostridium difficile Associated Disease in Scottish Hospitals. Edinburgh: Scottish Government Health Department, 2008.
26. Health and Social Care Information Centre. What is OPCS-4? http://systems.hscic.gov.uk/data/clinicalcoding/codingstandards/opcs4/background.
27. Wagner AK, Soumerai SB, Zhang F et al. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002; 27: 299-309.
28. KDIGO Clinical Practice Guideline for Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. 2012. http://www.kdigo.org/clinical-practice-guidelines/pdf/KDIGO%20AKI% 20Guideline.pdf.
29. Health Informatics Centre Services. University of Dundee Health Informatics Centre. http://www.medicine.dundee.ac.uk/hic.
30. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
31. Zhang F, Wagner AK, Soumerai SB et al. Methods for estimating confidence intervals in interrupted time series analyses of health interventions. J Clin Epidemiol 2007; 62: 143-8.
32. Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika 1965; 52: 3-4.
33. Durbin J, Watson GS. Testing for serial correlation in least squares regression. I. Biometrika 1950; 37: 409-28.
34. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. Philadelphia: Lippincott Williams & Wilkins, 2008.
35. Davenport A, Stevens P. UK Renal Association Clinical Practice Guidelines: Module 5 Acute Kidney Injury. 2008. http://www.renal.org/docs/default-source/guidelines-resources/Module-5-Acute-Kidney- Injury-4th-Edition.pdf?sfvrsn=0.
36. Thakar CV, Christianson A, Freyberg R et al. Incidence and outcomes of acute kidney injury in intensive care units: a Veterans Administration study. Crit Care Med 2009; 37: 2552-8.
37. Uchino S, Kellum JA, Bellomo R et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005; 294: 813-8.
38. Stevens PE, Tamimi NA, Al-Hasani MK et al. Non-specialist management of acute renal failure. QJM 2001; 94: 533-40.
39. National Institute for Health and Care Excellence (NICE). Clostridiumdifficile Infection: Riskwith Broad-SpectrumAntibiotics. 2015; 30. https://www. nice.org.uk/advice/esmpb1/chapter/Full-evidence-summary-medicinesand-prescribing-briefing.
40. Vernaz N, Hill K, Leggeat S et al. Temporal effects of antibiotic use and Clostridium difficile infections. J Antimicrob Chemother 2009; 63: 1272-5.
41. Al-Obaydi W, Smith CD, Foguet P. Changing prophylactic antibiotic protocol for reducing Clostridium difficile-associated diarrhoeal infections. J Orthop Surg 2010; 18: 320-3.
42. Connaghan J. Update to the Clostridium difficile HEAT Target. Scottish Government General Health & Social Care Department, 2013. http://www.gov.scot/About/Performance/scotPerforms/partnerstories/NHSScotlandperformance/CDiffTargetUpdate.
43. Annual Epidemiological Commentary: Mandatory MRSA, MSSA and E. coli Bacteraemia and C. difficile Infection data, 2013/14. Department of Health, 2014. https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/330529/HCAI-mandatory-surveillance-annual- epidemiological-commentary-2013-14.pdf.
44. Higgins JPT, Ramsey C, Reeves BC et al. Issues relating to study design and risk of bias when including non-randomized studies in systematic reviews on the effects of interventions. Res Synth Methods 2013; 4: 12-25.
45. Ramsay CR, Matowe L, Grilli R et al. Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies. Int J Technol Assess Health Care 2003; 19: 613-23.